Court Opinion

ID: 2759735
Source: CourtListenerOpinion
Date Created: 2014-12-11 17:01:26.36984+00
Date Added: 2024-06-11T11:13:48.163645
License: Public Domain

In the United States Court of Federal Claims
                                     OFFICE OF SPECIAL MASTERS
                                              No. 14-195V
                                          (Not to be published)

*****************************
                            *
MIRANDA HOFFMAN,            *                                             Filed: November 20, 2014
                            *
               Petitioner,  *
                            *                                             Decision by Stipulation; Damages;
          v.                *                                             Attorneys’ Fees and Costs;
                            *                                             Meningococcal Conjugate
SECRETARY OF HEALTH AND     *                                             (Menectra) Vaccine; Guillain–Barré
HUMAN SERVICES,             *                                             Syndrome (“GBS”)

                            *
                           Respondent.
                            *
                            *
*****************************

Milton Clay Ragsdale, IV, Ragsdale LLC, Birmingham, AL, for Petitioner.

Lindsay Corliss, U.S. Dep’t of Justice, Washington, D.C., for Respondent.

      DECISION AWARDING DAMAGES AND ATTORNEYS’ FEES AND COSTS1

       On March 10, 2014, Miranda Hoffman filed a petition seeking compensation under the
National Vaccine Injury Compensation Program.2 Petitioner alleges that as a result of receiving
the Meningococcal Conjugate (Menectra) vaccine on January 20, 2012 she suffered from
Guillain–Barré syndrome (“GBS”) and that she experienced the residual effects of this injury for
more than six months.

1
  Because this decision contains a reasoned explanation for my action in this case, it will be posted on the website of
the United States Court of Federal Claims, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347,
§ 205, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). As provided by 42 U.S.C. §
300aa-12(d)(4)(B), however, the parties may object to the inclusion of certain kinds of confidential information. To
do so, Vaccine Rule 18(b) provides that each party has 14 days within which to request redaction “of any
information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is
privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute
a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the decision will be available to the
public. Id.
2
  The National Vaccine Injury Compensation Program comprises Part 2 of the National Childhood Vaccine Injury
Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755 (codified as amended, 42 U.S.C.A. ' 300aa-10 – 34 (2006))
[hereinafter “Vaccine Act” or “the Act”]. Individual sections references hereafter will be to ' 300aa of the Act.
        Respondent denies that Petitioner’s GBS was caused-in-fact by her meningococcal
vaccination, and denies that the vaccine caused any other injury or her current disabilities.
Nonetheless both parties, while maintaining their above-stated positions, agreed in a stipulation
(filed on November 19, 2014) that the issues before them can be settled and that a decision
should be entered awarding Petitioner compensation.

         In a separate stipulation (filed on November 17, 2014), the parties indicated that they had
also reached an agreement regarding attorneys’ fees and costs. The stipulation laid out the
amount of compensation that should be awarded to Petitioner’s attorney in the form of a check
made payable jointly to Petitioner and Petitioner’s counsel. In compliance with General Order
#9, it also indicated that no out-of-pocket litigation related costs had been incurred by Petitioner
in proceeding on the petition.

        I have reviewed the file, and based upon that review, I conclude that the parties’
stipulations are reasonable. I therefore adopt them as my decision in awarding damages, and
attorneys’ fees and costs, on the terms set forth therein.

        The damages stipulation (a copy of which is attached) awards:

                  A lump sum of $350,000.00 in the form of a check payable to Petitioner. The
                   amount represents compensation for all damages that would be available under
                   42 U.S.C. § 300aa-15(a).

Stipulation ¶ 8.

        The attorneys’ fees and costs stipulation awards:

                  A lump sum of $18,693.49 in the form of a check payable jointly to Petitioner
                   and Petitioner’s attorney, M. Clay Ragsdale, Esq. for attorneys’ fees and costs
                   available under 42 U.S.C. § 300aa-15(e).

Stipulation ¶ 8.

        I approve a Vaccine Program award in the requested amounts set forth above to be made
to Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the
clerk of the court is directed to enter judgment herewith.3

        IT IS SO ORDERED.

                                                                /s/ Brian H. Corcoran
                                                                   Brian H. Corcoran
                                                                   Special Master
3
  Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by each filing (either jointly or
separately) a notice renouncing their right to seek review.

                                                      2